TRVN — Trevena Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $19.42m
- $3.13m
Trevena Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Trevena Q2 EPS USD -0.23
Brief: Trevena Announces $2M Non-Dilutive Financing Tranche And Reduction In Outstanding Liabilities In Connection With Existing Ex-Us Royalty Financing
U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone
U.S. STOCKS ON THE MOVE-Allstate, MicroStrategy, AutoZone
U.S. STOCKS ON THE MOVE-Dell, Hewlett Packard Enterprise, Accenture
Trevena rises on positive preclinical results for experimental drug
Brief: Trevena Says TRV045 Did Not Show A Statistically Significant Effect In Preliminary Preclinical Model Of Epileptogenesis
Trevena Inc reports results for the quarter ended in January - Earnings Summary
Brief: Trevena- Got Letter From Nasdaq Hearings Panel Granting Extension Until August 28, To Regain Compliance With Nasdaq Continued Listing Requirements
Brief: Trevena Q1 EPS USD -0.36
Trevena Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Trevena Inc Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq On April 5
Trevena Inc reports results for the quarter ended in December - Earnings Summary
Trevena Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Trevena Awarded OLINVYK Agreement With Premier, Inc.
Brief: Trevena Files For Mixed Shelf Of Upto $200 Million - SEC Filing
Brief: Trevena Q3 EPS USD -0.57
Brief: Trevena Inc - Leon O. Moulder, Jr. Informed Co Of His Planned Retirement From Board, Effective As Of December 31